Blue Goat Cyber notes that the device sits FDA cleared and unsellable, waiting on an attestation that can take three to twelve months to land.
Public source
Publisher name
Public post
A SaMD medical device got FDA cleared, and the manufacturer assumed the hard part was over. Then, hospitals asked for SOC 2. They thought market access was gonna be easy…
Company
Blue Goat Cyber
We provide turnkey medical device cybersecurity services for FDA premarket submissions and postmarket management.
- Industry
- Medical Equipment Manufacturing
- Location
- Scottsdale, US
- Company size
- 11–50 employees
About Blue Goat Cyber
Full-Service Medical Device Cybersecurity for Premarket Submissions and Postmarket Management Medical device manufacturers face immense pressure to innovate while ensuring patient safety and meeting rigorous FDA cybersecurity requirements. The complexity of these challenges can be overwhelming, with the risk of vulnerabilities threatening not just compliance but patient lives. You want to create life-saving devices that patients and healthcare providers can trust. But navigating cybersecurity requirements, building robust threat models, and preparing FDA submissions can pull focus away from your core mission. It’s easy to feel stuck, wondering if your device is truly secure and compliant. At the heart of the issue is a need for clarity, confidence, and guidance through the cybersecurity landscape. That’s where Blue Goat Cyber comes in. We specialize in helping manufacturers create secure devices that meet FDA eSTAR guidelines while protecting patient safety. Our proven processes, fixed-fee pricing, and expert support ensure that your devices are secure and compliant without disrupting your innovation. When you partner with Blue Goat Cyber, the path becomes clear. By addressing cybersecurity early, managing risks effectively, and implementing robust security measures, you can move forward with confidence. Your devices will not only meet regulatory expectations but also demonstrate your commitment to patient safety. Imagine the peace of mind that comes with knowing your devices are secure, compliant, and ready to improve lives. With Blue Goat Cyber’s guidance, you can focus on advancing technology while leaving cybersecurity challenges behind. Your reputation as a trusted innovator grows, and your patients are safer because of it. The stakes are high, but the solution is within reach. You’re building the future of healthcare—Blue Goat Cyber ensures nothing holds you back.
See moreLatest activity
Latest activity from Blue Goat Cyber
5 signals
Legal & Regulatory
Blue Goat Cyber documented all of the cybersecurity labeling and tamper-proof seal documentation for a 20-year-old medical imaging device deployed in 15 locations.
Legal & Regulatory
Blue Goat Cyber announced that a SaMD medical device got FDA cleared.
Legal & Regulatory
Blue Goat Cyber noted that the FDA added clarity on what counts as a cyber device in its February 2026 guidance.
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
C2A Security
C2A Security notes that Boston Scientific said new monitoring communicators cannot be activated for some newly implanted cardiac devices, and newly implanted cardiac monitors cannot pair with the patient monitoring app, resulting in recorded episode data not reaching the remote monitoring system until pairing is restored.
Legal & Regulatory
D.med Software
D.med Software highlights that the Cyber Resilience Act is moving from planning to practical readiness, requiring manufacturers to comply with reporting obligations for actively exploited vulnerabilities and severe security incidents affecting products with digital elements starting from July 2026.
Legal & Regulatory
Kaleidex Group
Kaleidex Group highlighted that the MHRA explored a potential development of a medical device licencing regime requiring a license issued by the MHRA rather than relying solely on third-party conformity assessment.
Legal & Regulatory
Beyond Motion FlexCo
Beyond Motion FlexCo classified its hardware as class I instead of class Im or IIa to make a decisive difference in development speed, certification cost, and investor story.
Legal & Regulatory
Anatomy IT